40 min listen
Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
FromKeeping Current
Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
FromKeeping Current
ratings:
Length:
71 minutes
Released:
Nov 27, 2023
Format:
Podcast episode
Description
Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer? Credit available for this activity expires: 11/20/23 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998605?ecd=bdc_podcast_libsyn_mscpedu
Released:
Nov 27, 2023
Format:
Podcast episode
Titles in the series (100)
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice: Experts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current